« Back
Home /
BRD9539

BRD9539

Manufacturer	MedChem Express
Category	Inhibitors & Compound Libraries Small Molecules
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Item no.	HY-15647-10mM
Targets	Histone Methyltransferase
CASRN	1374601-41-8
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	BRD9539 is a histone methyltransferase G9a inhibitor with an IC50 of 6.3 μM. BRD9539 also inhibits PRC2 activity and is inactive against SUV39H1, NSD2 and DNMT1[1].
StorageTemperature	-20°C, 3 years; 4°C, 2 years (Powder)
Shipping	Room Temperature
Manufacturers Applications	Cancer-Kinase/protease
MolecularWeight	399.44
Clinical_Information	No Development Reported
Manufacturers Research_Area	Cancer
Solubility	DMSO : 16.67 mg/mL (ultrasonic)
Manufacturers Target	Histone Methyltransferase
Isoform	EHMT2/G9a/KMT1C
Pathway	Epigenetics
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-15647-10mM-safety-datasheet.pdf